ISSN 1662-4009 (online)

ey0020.1-12 | Autoimmune Thyroid Disease | ESPEYB20

1.12. Impact of definitive surgery for Graves' disease on adolescent disease-specific quality of life and psychosocial functioning

S Halada , JA Baran , A Isaza , T Patel , L Sisko , K Kazahaya , NS Adzick , WR Katowitz , L Magee , AJ Bauer

Brief summary: Treatment of GravesÂ’ disease comprises anti-thyroid drugs, radioactive iodine ablation or total thyroidectomy (1,2). While definitive treatment of GravesÂ’ disease is widely used in adults, anti-thyroid drug treatment is often used in the pediatric age group over years (1,2). The presented prospective monocenter study provides detailed information on quality of life of adolescents undergoing total thyroidectomy.Two recent studies ...

ey0021.9-11 | Thyroid Issues in Cancer Survivors | ESPEYB21

9.11. Thyroid ultrasound screening in childhood cancer survivors following radiotherapy

JA Baran , S Halada , AJ Bauer , Y Li , A Isaza , T Patel , L Sisko , JP Ginsberg , K Kazahaya , NS Adzick , S Mostoufi-Moab

Brief Summary: This retrospective study assessed the outcome of thyroid ultrasound (US) surveillance in childhood cancer survivors (CCS) exposed to radiotherapy (RT). 306 CCS were monitored with thyroid US. Patients received TBI (45%) and/or RT to craniospinal (44%), chest (11%), and neck regions (6%). Thyroid US surveillance was started at a median interval of 9.1 years after RT; 150 patients (49%) had thyroid nodule(s); 44 patients underwent surgery, and 28 had a final diagn...